Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Locations sections were reorganized: a main Locations section added with state subheadings (California, Illinois, New York, North Carolina, Ohio) and the prior state-specific sections removed; the page revision notes show an update from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T17:29:42.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Publication note now states that PubMed entries are automatically filled and may not pertain to the study, and the revision tag has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T20:57:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site-wide funding-status notice near the top of the page has been removed. The study details and related information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:22:50.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The Study Details page shows only minor visual/layout changes with no updates to core content such as eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:23.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:30:15.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Expanded core topics to include Sudden Infant Death Syndrome and related terms; removed the older version label (v3.0.2) in favor of v3.1.0.
    Difference
    1%
    Check dated 2025-09-28T10:36:43.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.